BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24074981)

  • 1. Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients.
    Naito S; Kinoshita H; Kondo T; Shinohara N; Kasahara T; Saito K; Takayama T; Masumori N; Takahashi W; Takahashi M; Terachi T; Ozono S; Naito S; Tomita Y
    Urology; 2013 Oct; 82(4):846-51. PubMed ID: 24074981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases.
    Kato S; Demura S; Murakami H; Yoshioka K; Shinmura K; Yokogawa N; Shimizu T; Kawahara N; Tsuchiya H
    Cancer Sci; 2021 Jun; 112(6):2416-2425. PubMed ID: 33780597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma.
    Ohtaki Y; Shimizu K; Aokage K; Nakao M; Yoshida J; Kamiyoshihara M; Sugano M; Takahashi Y; Nakazawa S; Nagashima T; Obayashi K; Hishida T; Tsuboi M; Mori S; Mun M; Okumura S; Igai H; Matsutani N; Mogi A; Kuwano H
    World J Surg; 2017 Mar; 41(3):771-779. PubMed ID: 27896403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
    Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
    Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Urol Oncol; 2021 Jan; 39(1):77.e17-77.e25. PubMed ID: 32863124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and meta-analysis.
    Zhao Y; Li J; Li C; Fan J; Liu L
    Int J Surg; 2017 May; 41():70-77. PubMed ID: 28351779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.
    Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G
    J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma.
    Shinohara N; Nonomura K; Abe T; Maruyama S; Kamai T; Takahashi M; Tatsugami K; Yokoi S; Deguchi T; Kanayama H; Oba K; Naito S
    Cancer Sci; 2012 Sep; 103(9):1695-700. PubMed ID: 22642767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience.
    Kudelin N; Bölükbas S; Eberlein M; Schirren J
    Ann Thorac Surg; 2013 Jul; 96(1):265-70: discussion 270-1. PubMed ID: 23731615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.
    van der Poel HG; Roukema JA; Horenblas S; van Geel AN; Debruyne FM
    Eur Urol; 1999; 35(3):197-203. PubMed ID: 10072620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.
    Kato S; Murakami H; Demura S; Nambu K; Fujimaki Y; Yoshioka K; Kawahara N; Tomita K; Tsuchiya H
    J Surg Oncol; 2016 Apr; 113(5):587-92. PubMed ID: 26846902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Long-Term Survival Following Pulmonary Metastasectomy of Renal Cell Carcinoma.
    Saricam M
    Urol J; 2020 Aug; 17(5):492-496. PubMed ID: 32869257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.
    Naito S; Yamamoto N; Takayama T; Muramoto M; Shinohara N; Nishiyama K; Takahashi A; Maruyama R; Saika T; Hoshi S; Nagao K; Yamamoto S; Sugimura I; Uemura H; Koga S; Takahashi M; Ito F; Ozono S; Terachi T; Naito S; Tomita Y
    Eur Urol; 2010 Feb; 57(2):317-25. PubMed ID: 19136199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience.
    Procházková K; Vodička J; Fichtl J; Krákorová G; Šebek J; Roušarová M; Hošek P; Brookman May SD; Hes O; Hora M; Třeška V
    Urol Int; 2019; 103(3):297-302. PubMed ID: 31434090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.